Recombinant vaccine against west nile virus
AssigneeMerial Limited
InventorsSHEENA MAY LOOSMORE, JEAN-CHRISTOPHE FRANCIS AUDONNET, JULES MAARTEN MINKE
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerial Limited
InventorsSHEENA MAY LOOSMORE, JEAN-CHRISTOPHE FRANCIS AUDONNET, JULES MAARTEN MINKE
Estimating the term…
An immunogenic or vaccine composition to induce an immune response or protective immune response against West Nile virus (WNV) in an animal susceptible to WNV. The composition includes a pharmaceutically or veterinarily acceptable vehicle or excipient, and a vector. The vector contains heterologous nucleic acid molecule(s), expresses in vivo in the animal WNV antigen, immunogen or epitope thereof, e.g., WNV E; WNV prM and E; WNV M and E; WNV prM, WNV M and E, WNV polyprotein prM-E, WNV polyprotein M-E, or WNV polyprotein prM-M-E. The composition can contain an adjuvant, such as carbomer. Methods for making and using such a composition, including prime-boost regimes and including as to differential diagnosis, are also contemplated.
1-29. (canceled)
A composition comprising a vector comprising a recombinant virus or DNA plasmid comprising a polynucleotide that encodes and expresses in vivo in an animal WNV (West Nile Virus) E, WNV M, WNV prM, WNV NS2A, WNV NS2B, WNV NS3, WNV polyprotein prM-E, WNV polyprotein M-E, WVN polyprotein prM-M, WNV polyprotein prM-M-E, or WNV polyprotein NS2A-NS2B-NS3.
Dependencies are inferred from the claim text.